This is firmed fixed purchase order for exploratory behavioral economics study

Ended Purchase Order Awarded Last action

Contract number
75F40122P00597
Awardee
Awarding agency
Obligated
$50,800

Award facts

Contract value 100% obligated
$50,800.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Not Competed · 1 offer Only One Source
Pricing
Firm Fixed Price
Place of performance
Calverton, MD 20705, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00006 · The purpose of this modification is to DE-obligate funds, cancel non-funded item 2, and close out the contract. -$46,200
Other Administrative Action P00005 · COR change. $0
Other Administrative Action P00004 · This modification is to change the official title to "risk/safety considerations and motivations for purchase and use of kratom and psychedelics alone and in… $0
Other Administrative Action P00003 · No cost extension . Adding in paperwork reduction act (PRA) required timeline. POP end date changed from 31 DEC 2023 to 30 june 2025. $0
Other Administrative Action P00002 $0
Other Administrative Action P00001 · This modification is to incorporate performance-based payments clause and pricing schedule. $0
Original award $97,000

About this award

Written by GovTribe AI ·

The Food and Drug Administration awarded a $50.8K firm fixed price purchase order to Brightfield Group LLC for an exploratory behavioral economics study, with performance in Calverton, Maryland and an ultimate completion date of June 30, 2025. This modification de-obligates funds, cancels the non-funded second item, and closes out the contract. The award carries no set-aside designation and was issued directly to the prime contractor without identified subcontractors.

Brightfield Group LLC is a data, research, and analytics service provider registered in the System for Award Management as a limited liability partnership. The company has established a track record with federal health agencies, particularly the FDA and Centers for Disease Control and Prevention, delivering specialized research services and data subscriptions to support regulatory decision-making and public health initiatives. This purchase order represents part of a broader $128K exploratory behavioral economics study portfolio that the FDA has awarded to Brightfield Group through June 2025.

Quick answers

Who was awarded contract 75F40122P00597?

75F40122P00597 was awarded to Brightfield Group LLC by Food and Drug Administration (Department of Health and Human Services) on September 29, 2022.

How much is contract 75F40122P00597 worth?

The government has obligated $50,800 on 75F40122P00597.

Was contract 75F40122P00597 competed?

The extent of competition for 75F40122P00597 was not competed. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login